2-amino-9-[(1S,5R,7R,8S,13S,15R,16R)-15-(6-aminopurin-9-yl)-10,16-dihydroxy-5-methyl-10-oxo-4,6,9,11,14-pentaoxa-10λ5-phosphatricyclo[11.3.0.05,8]hexadecan-7-yl]-1H-purin-6-one

C21H25N10O9P — CID 137149361

IUPAC2-amino-9-[(1S,5R,7R,8S,13S,15R,16R)-15-(6-aminopurin-9-yl)-10,16-dihydroxy-5-methyl-10-oxo-4,6,9,11,14-pentaoxa-10λ5-phosphatricyclo[11.3.0.05,8]hexadecan-7-yl]-1H-purin-6-one
SMILESC[C@]12OCC[C@H]3[C@@H](O)[C@H](n4cnc5c(N)ncnc54)O[C@@H]3COP(=O)(O)O[C@H]1[C@H](n1cnc3c(=O)[nH]c(N)nc31)O2
InChIInChI=1S/C21H25N10O9P/c1-21-13(19(39-21)31-7-27-11-16(31)28-20(23)29-17(11)33)40-41(34,35)37-4-9-8(2-3-36-21)12(32)18(38-9)30-6-26-10-14(22)24-5-25-15(10)30/h5-9,12-13,18-19,32H,2-4H2,1H3,(H,34,35)(H2,22,24,25)(H3,23,28,29,33)/t8-,9-,12-,13+,18-,19-,21-/m1/s1
InChIKeyPTKVMEBGJBTVIR-CVYYSHLOSA-N
MW592.47 g/mol
LogP-0.83
Rot. Bonds2

About 2-amino-9-[(1S,5R,7R,8S,13S,15R,16R)-15-(6-aminopurin-9-yl)-10,16-dihydroxy-5-methyl-10-oxo-4,6,9,11,14-pentaoxa-10λ5-phosphatricyclo[11.3.0.05,8]hexadecan-7-yl]-1H-purin-6-one

2-amino-9-[(1S,5R,7R,8S,13S,15R,16R)-15-(6-aminopurin-9-yl)-10,16-dihydroxy-5-methyl-10-oxo-4,6,9,11,14-pentaoxa-10λ5-phosphatricyclo[11.3.0.05,8]hexadecan-7-yl]-1H-purin-6-one (PubChem CID 137149361) has the molecular formula C21H25N10O9P and a molecular weight of 592.47 g/mol. Its IUPAC name is 2-amino-9-[(1S,5R,7R,8S,13S,15R,16R)-15-(6-aminopurin-9-yl)-10,16-dihydroxy-5-methyl-10-oxo-4,6,9,11,14-pentaoxa-10λ5-phosphatricyclo[11.3.0.05,8]hexadecan-7-yl]-1H-purin-6-one.

Molecular Properties

Compound Name2-amino-9-[(1S,5R,7R,8S,13S,15R,16R)-15-(6-aminopurin-9-yl)-10,16-dihydroxy-5-methyl-10-oxo-4,6,9,11,14-pentaoxa-10λ5-phosphatricyclo[11.3.0.05,8]hexadecan-7-yl]-1H-purin-6-one
PubChem CID137149361
Molecular FormulaC21H25N10O9P
Molecular Weight592.47 g/mol
Exact Mass592.15
IUPAC Name2-amino-9-[(1S,5R,7R,8S,13S,15R,16R)-15-(6-aminopurin-9-yl)-10,16-dihydroxy-5-methyl-10-oxo-4,6,9,11,14-pentaoxa-10λ5-phosphatricyclo[11.3.0.05,8]hexadecan-7-yl]-1H-purin-6-one
SMILESC[C@]12OCC[C@H]3[C@@H](O)[C@H](n4cnc5c(N)ncnc54)O[C@@H]3COP(=O)(O)O[C@H]1[C@H](n1cnc3c(=O)[nH]c(N)nc31)O2
InChIInChI=1S/C21H25N10O9P/c1-21-13(19(39-21)31-7-27-11-16(31)28-20(23)29-17(11)33)40-41(34,35)37-4-9-8(2-3-36-21)12(32)18(38-9)30-6-26-10-14(22)24-5-25-15(10)30/h5-9,12-13,18-19,32H,2-4H2,1H3,(H,34,35)(H2,22,24,25)(H3,23,28,29,33)/t8-,9-,12-,13+,18-,19-,21-/m1/s1
InChIKeyPTKVMEBGJBTVIR-CVYYSHLOSA-N
XLogP-0.83
TPSA262.89 Ų
H-Bond Donors5
H-Bond Acceptors17
Rotatable Bonds2
Heavy Atoms41
Complexity

Lipinski Rule of Five

2 violations

RuleValue
MW ≤ 500592.47
LogP ≤ 5-0.83
H-Bond Donors ≤ 55
H-Bond Acceptors ≤ 1017

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'phosphor', 'substructure': 'N/A'}

Analyze 2-amino-9-[(1S,5R,7R,8S,13S,15R,16R)-15-(6-aminopurin-9-yl)-10,16-dihydroxy-5-methyl-10-oxo-4,6,9,11,14-pentaoxa-10λ5-phosphatricyclo[11.3.0.05,8]hexadecan-7-yl]-1H-purin-6-one with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 2-amino-9-[(1S,5R,7R,8S,13S,15R,16R)-15-(6-aminopurin-9-yl)-10,16-dihydroxy-5-methyl-10-oxo-4,6,9,11,14-pentaoxa-10λ5-phosphatricyclo[11.3.0.05,8]hexadecan-7-yl]-1H-purin-6-one?
The IUPAC name of 2-amino-9-[(1S,5R,7R,8S,13S,15R,16R)-15-(6-aminopurin-9-yl)-10,16-dihydroxy-5-methyl-10-oxo-4,6,9,11,14-pentaoxa-10λ5-phosphatricyclo[11.3.0.05,8]hexadecan-7-yl]-1H-purin-6-one (CID 137149361) is 2-amino-9-[(1S,5R,7R,8S,13S,15R,16R)-15-(6-aminopurin-9-yl)-10,16-dihydroxy-5-methyl-10-oxo-4,6,9,11,14-pentaoxa-10λ5-phosphatricyclo[11.3.0.05,8]hexadecan-7-yl]-1H-purin-6-one.
What is the SMILES notation for 2-amino-9-[(1S,5R,7R,8S,13S,15R,16R)-15-(6-aminopurin-9-yl)-10,16-dihydroxy-5-methyl-10-oxo-4,6,9,11,14-pentaoxa-10λ5-phosphatricyclo[11.3.0.05,8]hexadecan-7-yl]-1H-purin-6-one?
The canonical SMILES for 2-amino-9-[(1S,5R,7R,8S,13S,15R,16R)-15-(6-aminopurin-9-yl)-10,16-dihydroxy-5-methyl-10-oxo-4,6,9,11,14-pentaoxa-10λ5-phosphatricyclo[11.3.0.05,8]hexadecan-7-yl]-1H-purin-6-one is C[C@]12OCC[C@H]3[C@@H](O)[C@H](n4cnc5c(N)ncnc54)O[C@@H]3COP(=O)(O)O[C@H]1[C@H](n1cnc3c(=O)[nH]c(N)nc31)O2.
What is the InChIKey of 2-amino-9-[(1S,5R,7R,8S,13S,15R,16R)-15-(6-aminopurin-9-yl)-10,16-dihydroxy-5-methyl-10-oxo-4,6,9,11,14-pentaoxa-10λ5-phosphatricyclo[11.3.0.05,8]hexadecan-7-yl]-1H-purin-6-one?
The InChIKey is PTKVMEBGJBTVIR-CVYYSHLOSA-N. The full InChI is InChI=1S/C21H25N10O9P/c1-21-13(19(39-21)31-7-27-11-16(31)28-20(23)29-17(11)33)40-41(34,35)37-4-9-8(2-3-36-21)12(32)18(38-9)30-6-26-10-14(22)24-5-25-15(10)30/h5-9,12-13,18-19,32H,2-4H2,1H3,(H,34,35)(H2,22,24,25)(H3,23,28,29,33)/t8-,9-,12-,13+,18-,19-,21-/m1/s1.
What are the key properties of 2-amino-9-[(1S,5R,7R,8S,13S,15R,16R)-15-(6-aminopurin-9-yl)-10,16-dihydroxy-5-methyl-10-oxo-4,6,9,11,14-pentaoxa-10λ5-phosphatricyclo[11.3.0.05,8]hexadecan-7-yl]-1H-purin-6-one?
2-amino-9-[(1S,5R,7R,8S,13S,15R,16R)-15-(6-aminopurin-9-yl)-10,16-dihydroxy-5-methyl-10-oxo-4,6,9,11,14-pentaoxa-10λ5-phosphatricyclo[11.3.0.05,8]hexadecan-7-yl]-1H-purin-6-one has a molecular weight of 592.47 g/mol, XLogP of -0.83, 2 rotatable bonds, 5 hydrogen bond donors, and 17 hydrogen bond acceptors.
Where does this data come from?
All data for 2-amino-9-[(1S,5R,7R,8S,13S,15R,16R)-15-(6-aminopurin-9-yl)-10,16-dihydroxy-5-methyl-10-oxo-4,6,9,11,14-pentaoxa-10λ5-phosphatricyclo[11.3.0.05,8]hexadecan-7-yl]-1H-purin-6-one is sourced from PubChem (CID 137149361), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).